Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Withdrawn 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia 6Leukemia, Myeloid, Acute 5Myelodysplastic Syndromes 4Lymphoma 4Lymphoma, Non-Hodgkin 3Graft vs Host Disease 3Congenital Abnormalities 3Anemia, Refractory, with Excess of Blasts 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Recurrence 1Neuroblastoma 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hematologic Neoplasms 1Genetic Diseases, Inborn 1Burkitt Lymphoma 1Blast Crisis 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 14fludarabine phosphate 13ruxolitinib 9Busulfan 9Antilymphocyte Serum 9fludarabine 8Peripheral Blood Stem Cell Transplantation 8Filgrastim 8Whole-Body Irradiation 7Cyclosporine 7Tacrolimus 6Radiotherapy 6Mycophenolic Acid 6Methylprednisolone 6Methotrexate 5Melphalan 5Cytarabine 5Cord Blood Stem Cell Transplantation 5Azacitidine 5Imatinib Mesylate 4Alemtuzumab 4ponatinib 3parsaclisib 3fedratinib 3Stem Cell Transplantation 3Rituximab 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Decitabine 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Myeloproliferative Disorders × Transplantation × Clear all
NCT00074490 2018-12-31

Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
442 enrolled 17 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡